This content is from: Patents
TC Heartland becoming 'major point of dispute' in ANDA cases
Innovators have to be more careful when bringing a single case against multiple infringers, especially when some generics – such as Mylan – are involved
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here